LONDON (AP) — AstraZeneca board rejects sweetened takeover offer from Pfizer. Recommended Stories Paramount delays Warner Bros. merger amid legal roadblocks Taco Bell ditches lettuce, offers $1 deals after cyclospora outbreak EU fines Google $1 billion over antitrust violations